The global acute migraine medication market is anticipated to grow at a significant CAGR of 12.6% during the forecast period (2022-2028). Migraine is a neurological condition characterized by headaches, nausea, inability to smell, heightened sensitivity to sound and light, and numbness, among other symptoms. These headaches develop on one side of the head and last for varying lengths of time and intensity. Ergot alkaloids, triptans, and other migraine treatments are available in the acute migraine medication market. The growing awareness of the different types of migraines and the development of advanced treatment options are propelling the growth of the market.
Acute migrain is more prevalent in women as compared to men due to hormonal changes in them during menstrual cycle, pregnancy, menopause, and use of oral contraceptive pills. According to the article published by Migrain Research Foundation in March 2021, 18% of women in the US suffers from migrains while only 6% of men suffers from this disorder. In men, the prevalence of migrain is higher before puberty.
A full report Acute Migraine Medication Market of is available at: https://orionmarketreports.com/acute-migraine-medication-market/102789/
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Type
- By Distribution Channel
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
· Competitive Landscape- Glaxo Smith Kline Plc, Astellas Pharma Inc., Amgen Inc., Bayer AG, AstraZeneca Plc, and Dr. Reddy’s Laboratories, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Acute Migraine Medication Market Report by Segment
By Type
- Triptans
- NSAIDs
- Others
By Distribution Channel
- Offline Channel
- Online Channel
Geographic coverage
- North America market size and/or volume
- Latin America market size and/or volume
- Europe market size and/or volume
- Asia-pacific market size and/or volume
- Rest of the world market size and/or volume
Recent Developments
- Market Overview and growth analysis
- Import and Export Overview
- Volume Analysis
- Current Market Trends and Future Outlook
- Market Opportunistic and Attractive Investment Segment
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
